Comparison of Prognostic Genomic Predictors in Colorectal Cancer

Yun Yong Park, Sung Sook Lee, Jae Yun Lim, Sang Cheol Kim, Sang Bae Kim, Bo Hwa Sohn, In Sun Chu, Sang Cheul Oh, Eun Sung Park, Woojin Jeong, Sung Soo Kim, Scott Kopetz, Ju Seog Lee

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Although several prognostic genomic predictors have been identified from independent studies, it remains unclear whether these predictors are actually concordant with respect to their predictions for individual patients and which predictor performs best. We compared five prognostic genomic predictors, the V7RHS, the ColoGuideEx, the Meta163, the OncoDX, and the MDA114, in terms of predicting disease-free survival in two independent cohorts of patients with colorectal cancer. Study Design: Using original classification algorithms, we tested the predictions of five genomic predictors for disease-free survival in two cohorts of patients with colorectal cancer (n = 229 and n = 168) and evaluated concordance of predictors in predicting outcomes for individual patients. Results: We found that only two predictors, OncoDX and MDA114, demonstrated robust performance in identifying patients with poor prognosis in 2 independent cohorts. These two predictors also had modest but significant concordance of predicted outcome (r>0.3, P<0.001 in both cohorts). Conclusions: Further validation of developed genomic predictors is necessary. Despite the limited number of genes shared by OncoDX and MDA114, individual-patient outcomes predicted by these two predictors were significantly concordant.

Original languageEnglish
Article numbere60778
JournalPLoS One
Volume8
Issue number4
DOIs
Publication statusPublished - 2013 Apr 23

Fingerprint

colorectal neoplasms
Colorectal Neoplasms
genomics
Genes
Disease-Free Survival
prediction
prognosis
experimental design
genes

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Park, Y. Y., Lee, S. S., Lim, J. Y., Kim, S. C., Kim, S. B., Sohn, B. H., ... Lee, J. S. (2013). Comparison of Prognostic Genomic Predictors in Colorectal Cancer. PLoS One, 8(4), [e60778]. https://doi.org/10.1371/journal.pone.0060778

Comparison of Prognostic Genomic Predictors in Colorectal Cancer. / Park, Yun Yong; Lee, Sung Sook; Lim, Jae Yun; Kim, Sang Cheol; Kim, Sang Bae; Sohn, Bo Hwa; Chu, In Sun; Oh, Sang Cheul; Park, Eun Sung; Jeong, Woojin; Kim, Sung Soo; Kopetz, Scott; Lee, Ju Seog.

In: PLoS One, Vol. 8, No. 4, e60778, 23.04.2013.

Research output: Contribution to journalArticle

Park, YY, Lee, SS, Lim, JY, Kim, SC, Kim, SB, Sohn, BH, Chu, IS, Oh, SC, Park, ES, Jeong, W, Kim, SS, Kopetz, S & Lee, JS 2013, 'Comparison of Prognostic Genomic Predictors in Colorectal Cancer', PLoS One, vol. 8, no. 4, e60778. https://doi.org/10.1371/journal.pone.0060778
Park YY, Lee SS, Lim JY, Kim SC, Kim SB, Sohn BH et al. Comparison of Prognostic Genomic Predictors in Colorectal Cancer. PLoS One. 2013 Apr 23;8(4). e60778. https://doi.org/10.1371/journal.pone.0060778
Park, Yun Yong ; Lee, Sung Sook ; Lim, Jae Yun ; Kim, Sang Cheol ; Kim, Sang Bae ; Sohn, Bo Hwa ; Chu, In Sun ; Oh, Sang Cheul ; Park, Eun Sung ; Jeong, Woojin ; Kim, Sung Soo ; Kopetz, Scott ; Lee, Ju Seog. / Comparison of Prognostic Genomic Predictors in Colorectal Cancer. In: PLoS One. 2013 ; Vol. 8, No. 4.
@article{0fb4ef06ee8849168b31ac3f3e2d95bf,
title = "Comparison of Prognostic Genomic Predictors in Colorectal Cancer",
abstract = "Background: Although several prognostic genomic predictors have been identified from independent studies, it remains unclear whether these predictors are actually concordant with respect to their predictions for individual patients and which predictor performs best. We compared five prognostic genomic predictors, the V7RHS, the ColoGuideEx, the Meta163, the OncoDX, and the MDA114, in terms of predicting disease-free survival in two independent cohorts of patients with colorectal cancer. Study Design: Using original classification algorithms, we tested the predictions of five genomic predictors for disease-free survival in two cohorts of patients with colorectal cancer (n = 229 and n = 168) and evaluated concordance of predictors in predicting outcomes for individual patients. Results: We found that only two predictors, OncoDX and MDA114, demonstrated robust performance in identifying patients with poor prognosis in 2 independent cohorts. These two predictors also had modest but significant concordance of predicted outcome (r>0.3, P<0.001 in both cohorts). Conclusions: Further validation of developed genomic predictors is necessary. Despite the limited number of genes shared by OncoDX and MDA114, individual-patient outcomes predicted by these two predictors were significantly concordant.",
author = "Park, {Yun Yong} and Lee, {Sung Sook} and Lim, {Jae Yun} and Kim, {Sang Cheol} and Kim, {Sang Bae} and Sohn, {Bo Hwa} and Chu, {In Sun} and Oh, {Sang Cheul} and Park, {Eun Sung} and Woojin Jeong and Kim, {Sung Soo} and Scott Kopetz and Lee, {Ju Seog}",
year = "2013",
month = "4",
day = "23",
doi = "10.1371/journal.pone.0060778",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Comparison of Prognostic Genomic Predictors in Colorectal Cancer

AU - Park, Yun Yong

AU - Lee, Sung Sook

AU - Lim, Jae Yun

AU - Kim, Sang Cheol

AU - Kim, Sang Bae

AU - Sohn, Bo Hwa

AU - Chu, In Sun

AU - Oh, Sang Cheul

AU - Park, Eun Sung

AU - Jeong, Woojin

AU - Kim, Sung Soo

AU - Kopetz, Scott

AU - Lee, Ju Seog

PY - 2013/4/23

Y1 - 2013/4/23

N2 - Background: Although several prognostic genomic predictors have been identified from independent studies, it remains unclear whether these predictors are actually concordant with respect to their predictions for individual patients and which predictor performs best. We compared five prognostic genomic predictors, the V7RHS, the ColoGuideEx, the Meta163, the OncoDX, and the MDA114, in terms of predicting disease-free survival in two independent cohorts of patients with colorectal cancer. Study Design: Using original classification algorithms, we tested the predictions of five genomic predictors for disease-free survival in two cohorts of patients with colorectal cancer (n = 229 and n = 168) and evaluated concordance of predictors in predicting outcomes for individual patients. Results: We found that only two predictors, OncoDX and MDA114, demonstrated robust performance in identifying patients with poor prognosis in 2 independent cohorts. These two predictors also had modest but significant concordance of predicted outcome (r>0.3, P<0.001 in both cohorts). Conclusions: Further validation of developed genomic predictors is necessary. Despite the limited number of genes shared by OncoDX and MDA114, individual-patient outcomes predicted by these two predictors were significantly concordant.

AB - Background: Although several prognostic genomic predictors have been identified from independent studies, it remains unclear whether these predictors are actually concordant with respect to their predictions for individual patients and which predictor performs best. We compared five prognostic genomic predictors, the V7RHS, the ColoGuideEx, the Meta163, the OncoDX, and the MDA114, in terms of predicting disease-free survival in two independent cohorts of patients with colorectal cancer. Study Design: Using original classification algorithms, we tested the predictions of five genomic predictors for disease-free survival in two cohorts of patients with colorectal cancer (n = 229 and n = 168) and evaluated concordance of predictors in predicting outcomes for individual patients. Results: We found that only two predictors, OncoDX and MDA114, demonstrated robust performance in identifying patients with poor prognosis in 2 independent cohorts. These two predictors also had modest but significant concordance of predicted outcome (r>0.3, P<0.001 in both cohorts). Conclusions: Further validation of developed genomic predictors is necessary. Despite the limited number of genes shared by OncoDX and MDA114, individual-patient outcomes predicted by these two predictors were significantly concordant.

UR - http://www.scopus.com/inward/record.url?scp=84876531360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876531360&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0060778

DO - 10.1371/journal.pone.0060778

M3 - Article

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e60778

ER -